AzTrials
AzTrials

StrokeNCT07578961

Combined Effects of Tactile Kinesthetic Stimulation With Neural Mobilization in Stroke Patients

A study testing Tactile kinesthetic stimulation with neural mobilization and kinesthetic therapy in people with Stroke, run by Riphah International University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Combined Effects of Tactile -kinesthetic stimulation with Neural mobilization on sensory and motor functions of upper limb in stroke patients Read more about this study

Who is it for?
Ages 45 to 65 years
Conditions the study is for
Stroke
What is being tested?
Tactile kinesthetic stimulation with neural mobilization and kinesthetic therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
53 participants
Where
1 sitePakistan
Study dates
5 Apr 2025to 6 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 45 - 65 years
  • Both gender Male and Female
  • Diagnosed with chronic stroke stated as occurring 6 month to 12 month .
  • Sensory impairment - loss of tactile and proprioception NSA ( < 7/12)
  • Motor impairment - lack in full strength and coordination ( Brunnstrom >3)
  • Scored 24 or higher on the Mini-Mental State Examination, indicating sufficient cognition to follow study instructions.

Who cannot join

  • Severe cognitive or communication difficulties that would prevent meaningful involvement in therapy or testing.
  • Comorbid conditions that impair upper-limb function, including arthritis, prior fractures, or similar disorders.
  • Neurological conditions other than stroke that could interfere with study outcomes
  • Engagement in any other rehabilitation program during the trial period.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Study site

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Combined Effects of Tactile Kinesthetic Stimulation With Neural Mobilization on Sensory and Motor Functions of the Upper Limb in Stroke Patients

Combined Effects of Tactile -kinesthetic stimulation with Neural mobilization on sensory and motor functions of upper limb in stroke patients

Read the detailed description

Stroke ranks among the primary causes of lasting disability, frequently leaving the upper limb weak, numb, or clumsy and thereby curtailing daily independence and overall well-being. Although multiple therapy regimens appear helpful, research to date Meestal tests each method alone, obscuring how paired sensory and motor targets might accelerate recovery. The present study investigates combined the effect of tactile-kinesthetic input with neural mobilization against standard care, hypothesizing that the blend will produce broader gains in sensation and movement.

This randomized clinical trial will be conducted at Ittefaq Hospital (Trust) Lahore and Gulab Devi Chest Hospital Lahore over duration of 11 months. The sample size will be (53) participants. Participants which meet the inclusion criteria will be taken through non-probability convenience sampling technique, which will further be randomized through lottery method. Group A (27) participants will be assigned to combined tactile kinesthetic stimulation plus neural mobilization and Group B (27)participants will be assigned to conventional therapy. Data will be collected through different assessment tools, including Fugyl-Meyer Assessment for motor function, Nottingham Sensory Assessment Scale (NAS) for sensory function. Pre-interventions assessments will be conducted for both groups. The effects of the interventions will be measured at pre-treatment and post-treatment of 6 weeks. Data analysis will be performed by using SPSS 26 software.

Conditions
Stroke
Being tested
Tactile kinesthetic stimulation with neural mobilization, kinesthetic therapy
Keywords
Chronic stroke rehabilitation, neural mobilization, tactile kinesthetic stimulation, tactile therapy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tactile kinesthetic stimulation with neural mobilizationOther

    The therapist rests a light touch on the limb, applying only the weight of fingertips Soft, gliding strokes travel across the skin, delivered with the very tips of the fingers Pressure remains steadily upon targeted patches of tissue without sliding away Measured, rhythmical strokes creep up and down the length of the arm or leg Smooth silk, rough jute, coarse sponge, and other materials are brushed over the skin in turn.Slowly glide the median nerve by extending wrist and fingers while gently abducting the shoulder.

  • kinesthetic therapyOther

    Median nerve mobilization: Slowly glide the median nerve by extending wrist and fingers while gently abducting the shoulder.

    Ulnar nerve mobilization: Control elbow flexion and wrist extension while holding shoulder in slight abduction Radial nerve mobilization: Passively flex the wrist, pronate the forearm, and depress the shoulder to slide the radial nerve

Study groups in NCT07578961
Study groupRoleWhat they receive
Combine effects of Tactile with neural of sensory and motor functions of upper limb strokeExperimentalTactile Kinesthetic with Neural Mobilization: participants receive TKS WITH NM for 20 mins for 3 days per week for 4 weeks
Receives: Other: Tactile kinesthetic stimulation with neural mobilization
Combine effects of Tactile with neural mobilization of sensory and motor functions of upper limb strActive comparatorTks With Nm receive 20 mins therapy for 3 days per week
Receives: Other: kinesthetic therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1.Fugl-Meyer Assessment (FMA)

    The Fugl-Meyer Assessment (FMA) was developed specifically for stroke survivors and is a performance-based tool that gauges sensorimotor deficits in people living with hemiplegia. The FMA examines five key areas: voluntary motor control, sensory perception, balance, passive joint range of motion, and joint-related pain. Within this battery, the motor section commands the most attention; it rates movement, coordination, and reflex activity in the arms and legs, yielding a ceiling score of 100 points (66 for the arm and 34 for the leg).

    Measured: baseline with 4 week

  2. 2.Nottingham Sensory Assessment (NSA)

    The Nottingham Sensory Assessment, or NSA, provides clinicians with a standard method for mapping sensory loss after a stroke. Designed to examine both arms and legs, it centers on three core domains: touch, proprioception, and stereognosis. Within the protocol, practitioners test responses to light touch, gentle pressure, pinprick, temperature changes, and passive joint positioning. Because around half of all stroke survivors carry hidden somatosensory deficits that often impede movement, the tool is essential for early identification.

    Measured: baseline with 4 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2026
  2. Study start5 Apr 2025
  3. Primary completion3 Jun 2026 (estimated)
  4. Study completion6 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
53 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07578961
Sponsor's protocol ID
REC/RCR&AHS/25/0216
Status last verified
May 2026
First submitted
5 May 2026
Last updated
11 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Battesha HHM, Wadee AN, Shafeek MM, Tawfick AM, Ibrahim HM. Maze Control Training on Kinesthetic Awareness in Patients with Stroke: A Randomized Controlled Trial. Rehabil Res Pract. 2022 Feb 24;2022:5063492. doi: 10.1155/2022/5063492. eCollection 2022.

    PubMed 35251715
  • Takahashi R, Koiwa M, Ide W, Okawada M, Akaboshi K, Kaneko F. Visually Induced Kinaesthetic Illusion Combined with Therapeutic Exercise for Patients with Chronic Stroke: A Pilot Study. J Rehabil Med. 2022 Apr 7;54:jrm00276. doi: 10.2340/jrm.v54.29.

    PubMed 35266005
  • Afzal MR, Pyo S, Oh MK, Park YS, Yoon J. Evaluating the effects of delivering integrated kinesthetic and tactile cues to individuals with unilateral hemiparetic stroke during overground walking. J Neuroeng Rehabil. 2018 Apr 16;15(1):33. doi: 10.1186/s12984-018-0372-0.

    PubMed 29661237

Questions about this trial

What is this clinical trial studying?

A study testing Tactile kinesthetic stimulation with neural mobilization and kinesthetic therapy in people with Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1.Fugl-Meyer Assessment (FMA) (time frame: baseline with 4 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07578961, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in